Boehringer Ingelheim bolsters biologics research and development with 230 million euro investment in new development center
BIBERACH, Germany–(BUSINESS WIRE)– New Biologicals Development Center in Biberach, Germany bundles biologics development, increases capacity and expands clinical supply network Increased development capacities reflect research...